Hepatitis C Treatment: An Existing Ongoing Revolution Marc BourlièreTarik Asselah Hepatitis C (M Bourlière and T Asselah, Section Editors) 09 November 2015 Pages: 251 - 252
Genotype 2 Patients: What is the Optimum Therapy so Far? Elisabetta DegasperiAlessio Aghemo Hepatitis C (M Bourlière and T Asselah, Section Editors) 06 October 2015 Pages: 253 - 259
HCV Genotype 1 Infection: IFN-Free Treatment with Direct-Acting Antivirals Available in 2015 Marc BourlièreTarik Asselah Hepatitis C (M Bourlière and T Asselah, Section Editors) 25 November 2015 Pages: 260 - 266
Hepatitis C Genotype 3: The Remaining Problem G. ChoiR. BahirwaniK. R. Reddy Hepatitis C (M Bourlière and T Asselah, Section Editors) 13 October 2015 Pages: 267 - 273
How Manage HCV Patients on Hemodialysis? Marion CorougeAnais Vallet-PichardStanislas Pol Hepatitis C (M Bourlière and T Asselah, Section Editors) 09 October 2015 Pages: 274 - 278
Does Nucleos(t)ide (NUC) Analogs Therapy in Hepatitis B Impact the Incidence of Liver Cancer? Walid S. AyoubPaul MartinPietro Lampertico Hepatitis B (J Lim, Section Editor) 16 October 2015 Pages: 279 - 283
Current Management of HBV/HDV Coinfection and Future Perspectives A. WrankeB. HeidrichH. Wedemeyer Hepatitis B (J Lim, Section Editor) 10 October 2015 Pages: 284 - 292